A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
Status:
Completed
Trial end date:
2021-06-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of DCR-PHXC in Children and
Adults with Primary Hyperoxaluria Type 1 (PH1) and Primary Hyperoxaluria Type 2 (PH2)